Priority Date: 11.07.12 (US 201261670355P)

AAV-MEDIATED GENE THERAPY FOR RPGR X-LINKED RETINAL DEGENERATION

  • Application ID: EP13816245
  • Status: GRANT OF PATENT INTENDED

Applicants

Technology company logo small
Technology Transfer Office
Research organisation logo small
Research Organisation

Attorney

Employment test 51 - 200 employees
Company dna appleyard lees ltd
operating since 1852
Headquarter in Halifax and 15 offices
active in Legal Services, IP Consulting, Matchmaking and Trading, and IP-related Communication Service

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 11.07.2012 - Priority Date (US 201261670355P)
  • 16.01.2014 - Publication A1 (WO2014011210)
  • 20.05.2015 - Publication A1 (EP2872183)

IPC Classification